Joan E Durbin

Title: Joan E Durbin: Innovator in Viral Research

Introduction

Joan E Durbin is a prominent inventor based in Sergeantsville, NJ (US). She has made significant contributions to the field of viral research, particularly in the development of innovative vaccines and therapeutic methods. With a total of two patents to her name, her work has the potential to impact public health significantly.

Latest Patents

One of her latest patents is focused on recombinant Newcastle disease viruses and their uses for the prevention of respiratory syncytial virus (RSV) disease or human metapneumovirus disease. This patent describes recombinant Newcastle disease viruses (NDVs) that comprise a packaged genome, which includes a transgene encoding an RSV F protein or an hMPV F protein. These recombinant NDVs are designed to immunize against RSV or hMPV, providing a promising avenue for disease prevention.

Another notable patent involves type I and type III interferon fusion molecules. This patent outlines fusion molecules composed of type I and type III interferon proteins, along with pharmaceutical compositions containing these molecules. The methods described aim to inhibit infections, treat cancer, and induce signaling of transcription of interferon-stimulated genes, showcasing her innovative approach to addressing various diseases.

Career Highlights

Joan E Durbin has worked with esteemed institutions such as Rutgers, the State University of New Jersey, and the Icahn School of Medicine at Mount Sinai. Her career reflects a commitment to advancing medical science through her research and inventions.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Sergei V Kotenko and Viralkumar Rameshkumar Davra. These collaborations have further enriched her research and contributed to her innovative work in the field.

Conclusion

Joan E Durbin's contributions to viral research and her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in the prevention and treatment of viral diseases.